Evidence map›Paper›PMID 40004703›Full record

ArticleJournal of clinical medicine2025

Gender Disparity in Oral Anticoagulation Therapy in Hospitalised Patients with Atrial Fibrillation During the Ongoing Syrian Conflict: Unbalanced Treatment in Turbulent Times.

Ibrahim Antoun, Alkassem Alkhayer, Aref Jalal Eldin, Alamer Alkhayer, Khaled Yazji, Riyaz Somani, G André Ng, Mustafa Zakkar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Endomyocardial Fibrosis Associated With Hypereosinophilic Syndrome: Diagnostic and Management Insights From a Case Report.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ibrahim AntounDepartment of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Groby Road, Leicester LE3 9QP, UK.ORCID 0000-0002-4374-7476
Alkassem AlkhayerDepartment of Internal Medicine, University of Tishreen's Hospital, Latakia P.O. Box 2230, Syria.
Aref Jalal EldinDepartment of Internal Medicine, University of Tishreen's Hospital, Latakia P.O. Box 2230, Syria.
Alamer AlkhayerDepartment of Internal Medicine, University of Tishreen's Hospital, Latakia P.O. Box 2230, Syria.
Khaled YazjiNIHR Leicester Biomedical Research Centre, Leicester LE3 9QP, UK.
Riyaz SomaniDepartment of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Groby Road, Leicester LE3 9QP, UK.ORCID 0000-0001-5162-3644
G André NgDepartment of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Groby Road, Leicester LE3 9QP, UK.ORCID 0000-0001-5965-0671
Mustafa ZakkarDepartment of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Groby Road, Leicester LE3 9QP, UK.

Funding

British Heart Foundation Programme RG/17/3/32,774Medical Research Council Biomedical Catalyst Developmental Pathway Funding Scheme MR/S037306/1National Institute of Health Research grant NIHR203327NIHR i4i grant NIHR204553
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cardiovascular diseasedeveloping worlddirect oral anticoagulantfemalesmalesvitamin K antagonist

Identifiers

PMID40004703
PMCPMC11855938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.